Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease
Xiao-yu Liang,1 Fen-Fang Hong,2 Shu-Long Yang1 1Department of Physiology, College of Medicine, Nanchang University, Nanchang, 330006, People’s Republic of China; 2Experimental Teaching Center, Nanchang University, Nanchang, 330031, People’s Republic of ChinaCorrespondence: Shu-Lo...
Saved in:
Main Authors: | Liang XY, Hong Ff, Yang SL |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/9c04d24d1f844b5e9681e2b6a9c1f542 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Astragaloside IV Inhibits Mitochondrial-Dependent Apoptosis of the Dorsal Root Ganglion in Diabetic Peripheral Neuropathy Rats Through Modulation of the SIRT1/p53 Signaling Pathway
by: Ben Y, et al.
Published: (2021) -
Current concepts of the pathogenesis of non-alcoholic fatty liver disease
by: Evgenia Pavlovna Kosobyan, et al.
Published: (2010) -
Research Progress on the Ability of Astragaloside IV to Protect the Brain Against Ischemia-Reperfusion Injury
by: Xianhui Kang, et al.
Published: (2021) -
The Mechanism Actions of Astragaloside IV Prevents the Progression of Hypertensive Heart Disease Based on Network Pharmacology and Experimental Pharmacology
by: Haoran Jing, et al.
Published: (2021) -
Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and Differences
by: N. V. Mikhaylova, et al.
Published: (2019)